NeoGenomics, Inc. (NEO) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neogenomics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.583 Greetings and welcome to the Neogenomics 00:00:03.583 -- 00:00:07.214 first quarter 2025 conference call. 00:00:07.214 -- 00:00:11.889 At this time, all participants are on a listen-only mode and a question and answer session 00:00:11.889 -- 00:00:14.662 will follow the formal presentation. 00:00:14.662 -- 00:00:19.127 If anyone should require operator assistance during the conference, please press star 00:00:19.127 -- 00:00:25.295 zero on your telephone keypad. Please note, this conference is being recorded. 00:00:25.295 -- 00:00:30.461 I will now turn the conference over to your host, Kendra Sweeney, VP of Investor 00:00:30.461 -- 00:00:33.923 Relations. Mom, you may begin. 00:00:34.065 -- 00:00:38.470 Thank you, Ali. Good morning, everyone, and welcome to the Neogenomics First Quarter 00:00:38.470 -- 00:00:43.679 2025 Financial Results Call. With me today to discuss the results are Tony 00:00:43.679 -- 00:00:48.964 Zook, Chief Executive Officer, Jeff Sherman, Chief Financial Officer, Warren 00:00:48.964 -- 00:00:51.165 Stone, President 00:00:51.165 -- 00:00:57.111 and Chief Operating Officer, and Andrew Lukowiak, Chief Innovation Officer. 00:00:57.111 -- 00:01:01.815 Additional members of the management team are available for Q&A, including Kareem Saad, 00:01:01.815 -- 00:01:06.759 Head of Strategy and Transformation, Ali Alevo, General Counsel and Head of Business 00:01:06.759 -- 00:01:11.497 Development, and Dr. Nate Montgomery, VP of Clinical Services. 00:01:11.497 -- 00:01:16.023 This call is being simultaneously webcast, and we will be referring to a slide presentation 00:01:16.023 -- 00:01:22.108 that has been posted to the investors tab on our website at ir.neogenomics.com. 00:01:22.531 -- 00:01:26.757 During this call, w...